Fujian Cosunter Pharmaceutical Co., Ltd. (300436.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap14.2B
Enterprise Value14.37B
P/E Ratio-58.25
PEG Ratio8.82
Price/Sales Ratio29.87
Price/Book Ratio14.84
Enterprise/Revenue28.9
Enterprise/EBITDA-90.99

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin-0.49
Operating Margin-0.26
AD

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.54

Income Statement

Revenue416.37M
Revenue/Share2.7
Gross Profit259.49M
EBITDA-103.28M
Net Income-217.85M
Diluted EPS-1.37

Balance Sheet

Total Cash826.08M
Total Cash/Share5.19
Total Debt410.21M
Total Debt/Equity0.5
Current Ratio2.07
Book Value Per Share5.92

Price History

52-Week Change-26.84
52-Week High149
52-Week Low70.5
Moving Average 50 Days81.51
Moving Average 200 Days100.05

Statistics

Average Volume3.62M
Shares Outstanding168.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.07
Last Split Factor2:1
Last Split DateSeptember 16, 2015
AD